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Letters to the EditorWe have some concerns about the
methodology of their study. The au-
thors retrospectively reviewed their
2002 to 2005 experience in cardiac
surgery and investigated the effect
of preoperative renal function on
intermediate-term survival. The
study is retrospective, and patients’
data were collected retrospectively.
Could the authors obtain the data
of all the patients undergoing either
type of surgery and include them in
the study? If they could not do so,
wouldn’t this be a bias in patient se-
lection? We are wondering about the
method of how the authors replaced
the missing variables at the time of
data collection. Although sometimes
unavoidable, the missing informa-
tion reduces the analytic possibilities
and quality of analysis. How was the
follow-up of patients performed?
Were patients followed until the
date of last report or was the
anniversary method or common
closing date method used? The per-
centage of patients with complete
follow-up should be stated in the
methodology.
The article also is missing data on
the ‘‘censoring’’ of the participants
when information on time to outcome
event is not available because of loss
to follow-up or nonoccurrence of
outcome event before the end of the
trial.
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BENEFIT MORE FROM
OFF-PUMP CORONARY
ARTERY BYPASS GRAFTING?
To the Editor:
Off-pump coronary artery bypass
grafting (CABG) has been performed
in a systematic way since the 1980s.
However the benefits observed over
the years were not as great as we
imagined in the beginning. The initial
benefits could be lost in the medium or
long term with angina recurrence and
the need for repeat revascularization.1
There are no doubts about the need
for specific training for surgeons
and for the whole team when perform-
ing off-pump surgery. The biggest
question right now is: Which patients
will benefit more from off-pump
CABG?
Polomsky and colleagues2
showed, in a recent study, not 1 but
3 interesting and important aspects
that aim to reduce the doubts con-
cerning off-pump CABG. Using the
Society of Thoracic Surgeons data-
base that contains more than
800,000 patients, they achieved re-
sults sufficiently powered to demon-
strate significant benefits that other
studies—although prospective ran-
domized and multicenter—failed to
achieve. These include improved
outcomes of off-pump CABG not
only in high-volume sites but also
among all participating sites (this is
probably due to the greater invest-
ment by all centers to prepare staff
members to perform surgery without
cardiopulmonary bypass), reduced
morbidity and operative mortality
among patients operated on without
cardiopulmonary bypass (several au-
thors have been able to demonstrate
lower morbidity, but few have
demonstrated benefits in mortality),
and—most important—the group of
patients who experience greater
benefit from off-pump CABG. Using
the predictive risk of mortality
score, they showed that the
greatest apparent benefit of reducing
morbidity and mortality in off-pumpardiovascular Surgery c January 2014CABG was in the group with
higher predictive risk of mortality
score.
In a more modest study published
last year,3 our group found similar
results. With just more than 1500
patients and using 2 risk scores
(one simple [European System for
Cardiac Operative Risk Evaluation
score] and another that is more com-
plex [2000 Bernstein-Parsonnet
score]), we showed lower mortality
among patients operated on without
cardiopulmonary bypass. We demon-
strated that after a certain cutoff (Eu-
ropean System for Cardiac Operative
Risk Evaluation score>4.5 or 2000
Bernstein-Parsonnet score >17.75)
off-pump CABG significantly reduces
the chances of operative mortality.
However this was not observed among
patients with lower surgical risk.
Puskas and colleagues4 made this
same observation.4
Classic studies have shown that
CABG has its greatest benefit when
performed complete and using at least
2 arterial grafts.5 For our patients at
low surgical risk we keep these 2 goals
in mind regardless of whether or not
we use cardiopulmonary bypass.
With the work by Puskas and
colleagues,4 our own experience, and
now with the data from Polomsky
and colleagues,2 it is important to
reconsider the best approach for
patients with higher surgical risk for
CABG. Clearly a base is being built
with strong scientific evidence that
this is the group that experiences the
most benefit from off-pump CABG.
This evidence allows not using CPB
to be the main surgical approach,
and complete revascularization and
greater use of arterial grafts in patients
with high surgical risk as the second
plan. The goal is clear: Reduced
operative mortality.
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PEPTIDE IN CHILDREN
UNDERGOING PEDIATRIC
CARDIAC SURGERY: JUST
A MARKER OF DISEASE
SEVERITY STRONGLY
RELATED TO AGE OR MUCH
MORE?
To the Editor:
We read with interest the article of
Radman and colleagues1 entitled,
‘‘The effect of preoperative nutritional
status on postoperative outcomes in
children undergoing surgery for
congenital heart defects in San Fran-
cisco (UCSF) and Guatemala City
(UNICAR),’’ recently published in
the Journal. We agree with Radman
and colleagues1 that body fat mass
and acute and chronicmalnourishment
are important determinants of worse
outcome in children undergoing
surgery1-4; the relationship of
these factors to preoperative B-type
natriuretic peptide (BNP) values,
however, merits further consideration.
Actually, Radman and colleagues1
included in their study a wideThe Journalspectrum of ages (interquartile range,
3.2-47.1 months) and congenital heart
diseases (from simple septal defects to
univentricular heart). It has been
widely demonstrated that preopera-
tive BNP values as well as postopera-
tive BNP variations should be
interpreted as the consequences of 2
major factors: disease severity and
age.2,3 The influence of these
variables is particularly remarkable
in the neonatal and infant setting,
because neonatal cardiac surgery
usually carries a higher surgical risk
as a result of the severity of the
disease2-4 and many maturational
variations in endocrine function
within the first month of life.2,3 The
cardiac natriuretic peptide system is
a relevant component of a complex
and integrated network that includes
the endocrine, nervous, and immune
systems.5 For the same age and dis-
ease severity, a huge number of bio-
logic substances, environmental
factors, and physiologic parameters
contribute to BNP response5; body
fat mass and malnutrition are only 2
factors among these. Unfortunately,
the small sample size (only 71 pa-
tients) of the study by Radman and
colleagues1 does not allow a risk strat-
ification analysis that includes all
these parameters. In particular, low
body fat mass and malnutrition,
frequently observed in children with
more severe cardiac defects,1,4 are
important factors that contribute to
the severity of the disease state and
in turn to the rise in BNP values.
In conclusion, recent data support
the use of BNP as a useful adjunct
prognostic and disease severity
marker in children undergoing cardiac
surgery. Both preoperative values and
postsurgical variations in BNP should
be interpreted first according to age
and disease severity2,3 and only
secondarily as the consequence of
additional factors, including
malnutrition and body fat mass.
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STANDBY: IS HISTORY
REPEATING ITSELF? AWORD
OF CAUTION
To the Editor:
Current practice guidelines require
that transcatheter aortic valve implan-
tation (TAVI) be performed by a heart
team composed of interventional car-
diologists and surgeons in a hybrid
operating room.1 The occurrence of
a case, treated in a hospital without
cardiac surgery on site, in which the
implanted prosthesis migrated into
the left ventricle and required surgical
removal, prompted this report.
A 69-year-old woman underwent
TAVI in a facility without on-site car-
diac surgery. Shortly after transfe-
moral implantation, the prosthesisry c Volume 147, Number 1 541
